New therapeutic nonpharmacological methodology in Parkinson's disease (PD) involves
cell and synaptic renewal or replacement to restore function of neuronal systems, including …

In Parkinson's disease (PD), the main pathology is a loss of nigrostriatal dopamine (DA)
neurons. Clinical trials with intrastriatal transplantation of human embryonic mesencephalic …

The main pathology underlying motor symptoms in Parkinson's disease (PD) is a rather
selective degeneration of nigrostriatal dopamine (DA) neurons. Intrastriatal transplantation …

A new therapeutic neurological and neurosurgical methodology involves cell implantation
into the living brain in order to replace intrinsic neuronal systems, that do not spontaneously …

✓ In this review, the authors discuss recent advances in the field of cell therapy for Parkinson
disease (PD). They compare and contrast recent clinical trials using fetal dopaminergic …

Clinical studies with intrastriatal transplants of human embryonic mesencephalic tissue have
provided proof-of-principle for the cell replacement strategy in Parkinson's disease (PD) …

Abstract Parkinson's disease (PD), one of the most frequent neurodegenerative disorders, is
primarily caused by the selective degeneration of specific neuronal populations, particularly …

Cell replacement therapy has been proposed as a means to replace lost dopaminergic
neurons in Parkinson's disease (PD). In most studies, the transplanted cells have been …

Stem cell replacement has emerged as the novel therapeutic strategy for Parkinson's
disease (PD). Control of motor behavior is lost in PD due to the selective degeneration of …

Although transplantation of mesencephalic tissue is considered a promising therapy for
Parkinson's disease (PD), its clinical use is still restricted to a very few cases. A major …